Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 2,854 shares at $74.50 ($210K) on 2022-03-03, disclosed to the SEC on 2022-03-07.
Open-market sale of $210k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 1,149 | $86K | 40.7% |
| 2 | $74.50 | 1,149 | $86K | 40.7% |
| 3 | $70.41 | 556 | $39K | 18.6% |
| Total | $73.70 avg | 2,854 | $210K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |